Lee Rosebush Offers Drug Approval Process Insights to Military Researchers

News / July 27, 2022

On June 27, 2022, Partner Lee Rosebush will speak about “The New Drug Approval Process: New Drug Research and Development,” as part of the Food and Drug Law Institute’s Introduction to Drug Law and Regulation virtual course. The audience for the course is the U.S. Army Medical Materiel Development Activity (USAMMDA), the agency within the Department of Defense that develops medical products for military service members. The course was offered to a broader audience for CLE credit in April 2022 and is being re-presented for the USAMMDA.

More about USAMMDA

Related Services

Related Industries